StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by valentinemassonon Aug 14, 2020 4:12am

188 Views

Post# 31406946

RE:Confirmation of earnings

A little disappointed here. 177 reads, all the input throughout the day from veterans , and no one at all has any clue when details of financials will be released? If it`s August 14th, there is no indication anywhere of pre market, post market, evening , delayed , if transparency is key here, *someone had better step up to the plate.

VM.

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks